Selective laser trabeculoplasty appears to cause transient corneal endothelial changes in most patients that have no impact on cell count or visual acuity. Further work is required to elucidate the mechanism of this phenomenon and any long-term impact.
The Certificate of Completion of Training (CCT) allows the holder to work as a consultant ophthalmologist in the UK or Europe. We present data identifying the post-CCT career outcomes of the 2007-2010 cohort. Analysis includes time taken to secure post, subspecialty interest and post location. The career outcome of CCT holders, identified from the Royal College of Ophthalmologists' database, was researched at a local, deanery, and national level. Data were obtained from over 85% of holders over the 4 years. The number of CCTs awarded between 2007 and 2010 has remained stable, with a mean of 69 being awarded each year (Figure 1). Around half of the CCT holders gained a consultant post within 1 year and over three quarters were in a consultant post within 2 years. Almost all the CCT holders were in a consultant post by 3 years (Table 1). The majority of consultant postings (90-96%) were identified as having a subspecialty interest (Figures 2 and 3). Medical retina was the most common, accounting for 25% of all posts, followed by oculoplastics (19%), vitreoretinal (14%), paediatrics and strabismus (12%), glaucoma (11%), and cornea (9%). Nine posts (4%) were identified in general ophthalmology or primary care. Regional trends have also remained stable (Figures 4 and 5). A mean of 51% of trainees stayed within the training deanery for their consultant post, 34% took up a position out of the region and 15% went overseas, most commonly Australia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.